share_log

Lyell Immunopharmashares Are Trading Lower After the Company Released Initial Clinical Data From Its Phase 1 Trial of LYL797.

Lyell Immunopharmashares Are Trading Lower After the Company Released Initial Clinical Data From Its Phase 1 Trial of LYL797.

Lyell免疫製藥股價下跌,因公司發佈LYL797第一期臨床數據。
Benzinga ·  06/27 09:25

Lyell Immunopharmashares Are Trading Lower After the Company Released Initial Clinical Data From Its Phase 1 Trial of LYL797.

Lyell免疫製藥股價下跌,因公司發佈LYL797第一期臨床數據。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論